苏利股份：第三季度净利润同比增长2750% 百菌清等原药产品及农药制剂销量增长

Core Insights - Sulih Holdings (603585.SH) reported a significant increase in revenue and net profit for Q3 2025, with revenue reaching 762 million yuan, a year-on-year growth of 26.00%, and net profit at 59.42 million yuan, a remarkable increase of 2750.24% [1] Financial Performance - For the first three quarters of 2025, the company achieved a revenue of 2.064 billion yuan, reflecting a year-on-year growth of 25.39%, while net profit stood at 139 million yuan, marking a substantial increase of 1522.38% [1] - The growth in revenue and gross profit was driven by the recovery in the agrochemical market, increased sales of active ingredients such as Bacillus thuringiensis, pyraclostrobin, and azoxystrobin, as well as a rise in the unit price of Bacillus thuringiensis [1] Cost Factors - Despite the positive financial results, the company faced challenges including increased depreciation and amortization from new production lines, as well as rising energy and labor costs [1]